Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
NEXT ECAU... READY TO BREAKOUT
0.0008'S FALLINGGGGGGGGGG ALMOST READY TO BREAKOUTTTT
GGSM!!!!!!
GGSM!!!!!!
0.0008'S FALLINGGGGGGGGGG ALMOST READY TO BREAKOUTTTT
0.0008'S FALLINGGGGGGGGGG ALMOST READY TO BREAKOUTTTT
GGSM!!!!!! Gold and Gemstone Mining Completed Acquisition of Gringo Viejo Project
GGSM!!!!!! Gold and Gemstone Mining Completed Acquisition of Gringo Viejo Project
GGSM 7'S SOON 0.001
GGSM!!!!!! Gold and Gemstone Mining Completed Acquisition of Gringo Viejo Project
GVDIGolden Valley Development (GVDI) Announces Expansion for Global Strategic Alliances Program
Vega Biofuels to Ship Large Biochar Order to International Retail Client for Testing
Looks good for a reversal here. watching.
Accumulation in kimjf, a lot of volume after news.
What software do you use for level 2?
Mine too!!!! This will pop!!!
Facts
1.) Athersys has over $50M in cash and only burns $4-5 per quarter and little debt
2.) Athersys MAPC (MultiStem) v. MSC better chance of success v competitor - see link
http://m-hikari.com/asb/asb2009/asb1-4-2009/liuASB1-4-2009.pdf
3.) Mesoblast trading 7x ATHX value and ATHX has better product - see above link
4.) Athersys has the most advanced stroke program - stroke worth $15-30 Billion annually - virtually no other alternatives for stroke treatment
5.) Athersys has the potential to get conditional approval for MultiStem in Japan - watch for Athersys commencing small Japanese studies - w/ conditional approvals ATHX becomes profitable and skyrockets
6.) Athersys' partnership with RTIX equates to milestone payments of $30M not including royalties
7.) The upcoming IBD results in April/May will provide significant validation for MultiStem, followed by stroke results thereafter
8.) Listen to 1 hour 3 mins - 1 hour 7 min of below
http://www.transplant.tv/videos/multistem-for-inflammatory-and-immune-conditions-and-transplantation
9.) Athersys is moving forward with their GvHD phase 2/3 study in the US which will add significant value, most likely advancing in Japan
10.) Athersys commencing P2 study for AMI and most likely will in Japan as well
11.) Athersys is continually evaluating MultiStem for solid organ transplant study that is ongoing, PVD / PAD / CLI, congestive heart failure, traumatic brain injury, spinal cord injury
12.) MultiStem is being evaluated in a patch form for diabetic foot ulcers (and they have other diabetes studies ongoing)
http://bit.ly/1c624Qw
13.) Athersys has a potential blockbuster weight loss drug and may advance on their own
14.) Short position at all time high with Negative Implied Borrow Rate - meaning shorts are in trouble
http://www.optionapps.com/2014/02/options-action-optionapps-top-5-for-2014-02-26/
15.) Watch for significant Japan partnership / probably with Pfizer
Hoping today is a green day, been invested since march avg of 1.79 waiting for the resultd on uc and stroke but i dont really want it to go lower, losing all my gains.
What do you think about them?